GILEAD SCIENCES INC Insider Trading for October 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for October 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 20.71 | 15,000 | 310,575 | 30,000 | |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 110.00 | 15,000 | 1,650,000 | 44,309 | 59.3 K to 44.3 K (-25.29 %) |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 20.71 | 15,000 | 310,575 | 59,309 | 44.3 K to 59.3 K (+33.85 %) |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 1,500 | 40,485 | 3,007 | |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 110.06 | 1,500 | 165,092 | 48,783 | 50.3 K to 48.8 K (-2.98 %) |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 26.99 | 1,500 | 40,485 | 50,283 | 51.8 K to 50.3 K (-2.90 %) |
| Oct 27 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 24.30 | 5,000 | 121,475 | 128,742 | |
| Oct 27 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 110.00 | 5,000 | 550,000 | 133,422 | 138.4 K to 133.4 K (-3.61 %) |
| Oct 27 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 24.30 | 5,000 | 121,475 | 138,422 | 133.4 K to 138.4 K (+3.75 %) |
| Oct 27 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 20.71 | 15,000 | 310,575 | 45,000 | |
| Oct 27 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 110.00 | 15,000 | 1,650,000 | 44,309 | 59.3 K to 44.3 K (-25.29 %) |
| Oct 27 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 20.71 | 15,000 | 310,575 | 59,309 | 44.3 K to 59.3 K (+33.85 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.76 | 1,600 | 38,008 | 142,400 | |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.60 | 68,400 | 1,614,240 | 0 | |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 101.18 | 25,319 | 2,561,749 | 165,168 | 190.5 K to 165.2 K (-13.29 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 99.96 | 15,376 | 1,537,000 | 190,487 | 205.9 K to 190.5 K (-7.47 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 99.25 | 26,105 | 2,590,817 | 205,863 | 232 K to 205.9 K (-11.25 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 98.02 | 3,200 | 313,655 | 231,968 | 235.2 K to 232 K (-1.36 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.76 | 1,600 | 38,008 | 235,168 | 233.6 K to 235.2 K (+0.69 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.60 | 68,400 | 1,614,240 | 233,568 | 165.2 K to 233.6 K (+41.41 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 200,000 | |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 99.93 | 34,151 | 3,412,709 | 1,029,108 | 1.1 M to 1 M (-3.21 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 99.08 | 50,799 | 5,033,368 | 1,063,259 | 1.1 M to 1.1 M (-4.56 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 98.04 | 15,050 | 1,475,446 | 1,114,058 | 1.1 M to 1.1 M (-1.33 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Oct 07 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 24.30 | 5,000 | 121,475 | 133,742 | |
| Oct 07 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 100.00 | 5,000 | 500,000 | 133,422 | 138.4 K to 133.4 K (-3.61 %) |
| Oct 07 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 24.30 | 5,000 | 121,475 | 138,422 | 133.4 K to 138.4 K (+3.75 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,820 | 73,819 | 12,071 | |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 180 | 4,858 | 4,507 | |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 98.59 | 2,000 | 197,180 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 40.56 | 1,820 | 73,819 | 50,783 | 52.6 K to 50.8 K (-3.46 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 26.99 | 180 | 4,858 | 48,963 | 49.1 K to 49 K (-0.37 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 24.30 | 5,000 | 121,475 | 138,742 | |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 98.58 | 300 | 29,573 | 133,422 | 133.7 K to 133.4 K (-0.22 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 97.68 | 1,485 | 145,049 | 133,722 | 135.2 K to 133.7 K (-1.10 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 97.09 | 5,215 | 506,308 | 135,207 | 140.4 K to 135.2 K (-3.71 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 24.30 | 5,000 | 121,475 | 140,422 | 135.4 K to 140.4 K (+3.69 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 300,000 | |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 97.97 | 62,500 | 6,122,950 | 3,948,066 | 4 M to 3.9 M (-1.56 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 97.14 | 87,500 | 8,499,339 | 4,010,566 | 4.1 M to 4 M (-2.14 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,098,066 | 3.9 M to 4.1 M (+3.80 %) |
| Oct 01 2015 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | A | 0.00 | 10 | 0 | 2,150 | |
| Oct 01 2015 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 82 | 0 | 18,495 | |
| Oct 01 2015 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 109 | 0 | 24,509 | |
| Oct 01 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 27 | 0 | 6,142 | |
| Oct 01 2015 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 19 | 0 | 4,212 |